Black women less likely to receive guideline-concordant therapy for ovarian cancer

November 9, 2022 11:23 am

by Matthew Shinkle

Black women in the U.S. appeared less likely than white women to receive guideline-concordant treatment for ovarian cancer, according to a study published in Journal of the National Comprehensive Cancer Network.

Even among white women, the … Read more

Eligibility Not Responsible for Under Representations in Cancer Clinical Trials

October 18, 2022 10:16 am

by Jessica Nye, PhD

Left image: Eligibility and opportunity for participation in cancer clinical trials was found to be similar across race, level of disadvantage, and residential area. Source: Getty Images

Eligibility was not found to drive disparities in clinical … Read more

Hannah C. Karpel, MS, Talks Increasing Clinical Trial Accrual in Patients With Gynecologic Malignancies Following NCI Call-to-Action

October 4, 2022 10:04 am

by Ariana Pelosci

A recent study presented at IGCS 2022 looking at clinical trial enrollment found that Black patients experienced the biggest increase in accrual following an NCI call-to-action for more diversity in clinical trials.

A recent single-institution study presented

Read more

ASCO, ACCC Issue Recommendations to Boost Clinical Trial Diversity

July 24, 2022 10:44 am

by Jason Harris

The American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC) have issued a joint statement outlining 6 recommendations for boosting participation among underserved communities.1

Increasing the racial and ethnic diversity in

Read more